SPOTLIGHT: FDA approves FluMist for young children


The FDA has approved MedImmune's no-needle FluMist vaccine for use in kids as young as 2; previously it could only be used in children 5 years and older. This is good news for MedImmune (and its new parent AstraZeneca), which has struggled to make FluMist a success since the drug was approved in 2003. Release